AXIOS August 22, 2024
Tina Reed

The Food and Drug Administration approved new formulations of both Moderna and the Pfizer-BioNTech COVID-19 vaccines on Thursday.

Why it matters: The approval comes as the number of COVID infections grows in more than two dozen states and respiratory virus season fast approaches.

State of play: CDC advisers in June recommended that people 6 months of age and older receive updated COVID-19 vaccines when they become available this fall.

  • The new vaccine doses are tailored to the KP.2 strain — a descendant of the highly contagious JN.1 variant. The KP variants account for almost 70% of all current cases in the U.S.
  • Officials said individuals who receive one of these updated...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, FDA, Govt Agencies, Healthcare System, Patient / Consumer, Pharma / Biotech, Provider, Public Health / COVID
Related Articles:
Trump names nominees to lead CDC, FDA, and his pick for surgeon general
Patient Dies in Gene Therapy Trial, But FDA Permits Neurogene to Proceed With Low Dose
New FDA Panel Weighs In on Regulating Generative AI in Healthcare
Johns Hopkins surgeon Makary is Trump’s pick to lead FDA
Trump's FDA Pick Is MedPage Today's Former Top Editor

Share This Article